Nome Químico: Diethyl 3,3'-((3,3'-(diazene-1,2-diyl)bis(4-(methylamino)benzoyl))bis(pyridin-2-ylazanediyl))(E)-dipropionate
Sorrisos: CNC1=CC=C(C(N(C2=CC=CC=N2)CCC(OCC)=O)=O)C=C1/N=N/C3=C(NC)C=CC(C(N(C4=CC=CC=N4)CCC(OCC)=O)=O)=C3
Inchi: InChI=1S/C9H19ClNO7PS/c1-3(10)4(11)7-5(12)6(13)8(9(17-7)20-2)18-19(14,15)16/h3-9,12-13H,11H2,1-2H3,(H2,14,15,16)/t3-,4+,5+,6-,7+,8+,9+/m0/s1
Novel method for separation and quantification of potential impurities by RP-HPLC from KSM stage to API stage of dabigatran mesylate
By Jhansi, T. Naga; Nagaraju, R.; Kumar, D. Jaya Deep; Rao, G. Nageswara
From International Journal of Pharmaceutical Sciences and Research (2021), 12(3), 1762-1779
Development and Validation of RP-UPLC Method for the Determination of Process and Degradant Impurities Present in Dabigatran Etexilate Mesylate Capsules Using High Strength Silica-T3 Sorbent Column
By Mantena, Bhaskara P. V.; Rao, Sumathi V.; Suryakala, D.; Ramakrishna, K.; Srikanth Reddy, R.
From Analytical Chemistry Letters (2016), 6(5), 595-611
Determination of dabigatran etexilate mesylate by HPLC
By Jia, Ling-xiao; Tang, Lei; Zhang, Shu-ting; Song, Rui-zhi; Gao, Zhan-wen
From Shipin Yu Yaopin (2015), 17(3), 195-197